DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
First antidote for reversal of anticoagulation with factor Xa inhibitors apixaban and rivaroxaban [Internet].
Eur Med Agency 2019 [cited November 30, 2021]. Accessed January 30, 2022 at:
https://www.ema.europa.eu/en/news/first-antidote-reversal-anticoagulation-factor-xa-inhibitors-apixaban-rivaroxaban
We do not assume any responsibility for the contents of the web pages of other providers.